Company: SXTPW
Filing Date: 2025-09-09
Form Type: 8-K
Source: 0001213900-25-085853
Chunk: 0

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-09-09
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01

Regulation FD Disclosure

Chief
Executive Officer, Geoff Dow, of the Company, is scheduled to provide certain investor information, commencing on September 9, 2025. The
slide package prepared by the Company for use in connection with this presentation is furnished herewith as Exhibit 99.1. All of the information
in the attached presentation is presented as of September 9, 2025, and the Company does not assume any obligation to update such information
in the future.

The
information included in this Form 8-K, as well as the exhibit referenced herein, shall not be deemed “filed” for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under
the Securities Act of 1933, as amended.

Item 9.01 Financial Statements and Exhibits